 A pill that actually blocks the BRAF called a NERC inhibitor. It's not FDA approved yet. It's on a compassionate use study. There's no placebo. Patient actually gets the drug. It's called Uluxarctonib, very flexible study where as a physician, I could adjust the dose and I could actually combine it with immunotherapy with Pembrolizumap. And we have the first patient experience of this and it's just the patient's now disease-free and so this patient was initially resistant to the combination of immunotherapy. But with the new clinical trial, she is in a full remission. She had a very, almost a football-sized tumor under her armpit. And with the combination of immunotherapy and the ERC inhibitor, her tumor shrunk enough that the surgeons were able to remove it. And there are only 20 viable melanoma cells remaining.